Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04683250
Title Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Helsinn Healthcare SA
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

TAS0953/HM06

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST